{"id":372336,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2018-10-01] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:40:18.693000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-09-27.html","snippet":"Notice: Prescription Drug List (PDL): Multiple additions October 1 st , 2018 Our file number: 18-112049-187 The purpose of this Notice of Amendment is to notify about the additions of: Baricitinib, Emicizumab, Erenumab, Tisagenlecleucel and Dalbavancin to the Prescription Drug…","rawSnapshotUrl":"/api/snapshots/raw/372336","browseUrl":"https://replay.healtharchive.ca/job-6/20260411164018/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-09-27.html#ha_snapshot=372336","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}